Non-toxic cross-reactivity with healthy tissues supports in vivo expansion and therapeutic efficacy of T cells engineered with synthetic antigen receptors
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2020
has subject area
- 1103 Clinical Sciences (FoR)
- Immunology (Science Metrix)
published in
- Cytotherapy Journal